GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioasis Technologies BIOAF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Bioasis Technologies — daily BIOAF Delayed
Market value
$7,941
Last close × shares
Volume
72.9k
Shares, 30 Oct 2026

About Bioasis Technologies

Its shares trade under the ticker BIOAF. It has been listed since 24 July 2007. In the fiscal year to 28 February 2021, it reported revenue of C$4.1m and net income of C$698,410. At that date it held total assets of C$3.3m and shareholders' equity of C$407,196.

biOasis Technologies, Inc. operates as a biopharmaceutical company. The company is headquartered in Burnaby, British Columbia. The company went IPO on 2007-07-24. The firm is engaged in the development of the xB3 platform, a technology for the delivery of therapeutics across the blood brain barrier (BBB) and the treatment of central nervous system (CNS) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. xB3 is based on a human transport protein found circulating at low levels in the blood. The xB3 platform has an efficacy in its ability to shuttle molecules across the blood-brain barrier and reach its targets within the brain through a process called receptor-mediated transcytosis. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Figures and description from our data supplier, not checked against the company's own report.

More about Bioasis Technologies →

Latest on Bioasis Technologies

Our reporting

We have not reported on Bioasis Technologies yet.

Next results

22 Jan 2027

Due on 22 Jan 2027. Analysts expect earnings of -0.01 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Bioasis Technologies's ticker?

Bioasis Technologies trades as BIOAF on its US listing, under ISIN CA09064N1033.

What was Bioasis Technologies's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

When does Bioasis Technologies next report results?

Results are expected on 22 Jan 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.